The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model

Abstract

Acute challenges of dipraglurant were efficacious on choreic and dystonic LID in the MPTP-macaque model. Dipraglurant pharmacokinetic variables were similar to those of levodopa, suggesting that both drugs can be co-administered simultaneously in further studies.